1	SRC-related	src-related	_	_	_	_	_	_	_
2	proto-oncogenes	proto-oncogene	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	transcription	transcription	_	_	_	_	_	_	_
5	factors	factor	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	primary	primary	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	:	:	_	_	_	_	_	_	_
12	modulation	modulation	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	cyclosporin	cyclosporin	_	_	_	_	_	_	_
15	A	A	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	FK506	FK506	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	T	t	_	_	_	_	_	_	_
4	lymphocytes	lymphocyte	_	_	_	_	_	_	_
5	induces	induce	_	_	_	_	_	_	_
6	transcription	transcription	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	genes	gene	_	_	_	_	_	_	_
9	encoding	encode	_	_	_	_	_	_	_
10	for	for	_	_	_	_	_	_	_
11	lymphokines	lymphokine	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Interleukin-2	interleukin-2	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	IL-2	il-2	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	gene	gene	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	controlled	control	_	_	_	_	_	_	_
9	transcriptionally	transcriptionally	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	cooperative	cooperative	_	_	_	_	_	_	_
13	activity	activity	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	specific	specific	_	_	_	_	_	_	_
16	trans-activating	trans-activating	_	_	_	_	_	_	_
17	factors	factor	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	bind	bind	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	IL-2	il-2	_	_	_	_	_	_	_
23	enhancer	enhancer	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Cyclosporin	Cyclosporin	_	_	_	_	_	_	_
2	A	A	_	_	_	_	_	_	_
3	(	(	_	_	_	_	_	_	_
4	CsA	CsA	_	_	_	_	_	_	_
5	)	)	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	FK506	FK506	_	_	_	_	_	_	_
8	inhibit	inhibit	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	production	production	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	IL-2	il-2	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	lymphocytes	lymphocyte	_	_	_	_	_	_	_
16	at	at	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	level	level	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	gene	gene	_	_	_	_	_	_	_
21	transcription	transcription	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	member	member	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	src	src	_	_	_	_	_	_	_
6	gene	gene	_	_	_	_	_	_	_
7	family	family	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	lymphocyte-specific	lymphocyte-specific	_	_	_	_	_	_	_
11	protein	protein	_	_	_	_	_	_	_
12	tyrosine	tyrosine	_	_	_	_	_	_	_
13	kinase	kinase	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	p56lck	p56lck	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	has	have	_	_	_	_	_	_	_
18	been	be	_	_	_	_	_	_	_
19	implicated	implicate	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	IL-2	il-2	_	_	_	_	_	_	_
22	production	production	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	CsA	CsA	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	found	find	_	_	_	_	_	_	_
4	not	not	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	inhibit	inhibit	_	_	_	_	_	_	_
7	lck	lck	_	_	_	_	_	_	_
8	gene	gene	_	_	_	_	_	_	_
9	expression	expression	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	nor	nor	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	activity	activity	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	lck	lck	_	_	_	_	_	_	_
17	gene	gene	_	_	_	_	_	_	_
18	product	product	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	CsA	CsA	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	FK506	FK506	_	_	_	_	_	_	_
6	inhibit	inhibit	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	appearance	appearance	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	DNA	DNA	_	_	_	_	_	_	_
11	binding	binding	_	_	_	_	_	_	_
12	activity	activity	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	factors	factor	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	bind	bind	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	NF-AT	nf-at	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	AP-1	ap-1	_	_	_	_	_	_	_
22	sites	site	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	IL-2	il-2	_	_	_	_	_	_	_
26	enhancer	enhancer	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	induction	induction	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NF-AT	NF-AT	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	AP-1	AP-1	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	induced	induce	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	same	same	_	_	_	_	_	_	_
13	stimuli	stimulus	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	stimulate	stimulate	_	_	_	_	_	_	_
16	IL-2	il-2	_	_	_	_	_	_	_
17	production	production	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	these	these	_	_	_	_	_	_	_
20	results	result	_	_	_	_	_	_	_
21	indicate	indicate	_	_	_	_	_	_	_
22	that	that	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	immunosuppressant	immunosuppressant	_	_	_	_	_	_	_
25	action	action	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	CsA	CsA	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	FK506	FK506	_	_	_	_	_	_	_
30	is	be	_	_	_	_	_	_	_
31	exerted	exert	_	_	_	_	_	_	_
32	at	at	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	level	level	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	these	these	_	_	_	_	_	_	_
37	trans-activating	trans-activating	_	_	_	_	_	_	_
38	factors	factor	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

